logo
  

Illinois Tool Works Q3 Profit Up, Lifts Full-year Earnings View - Update

Industrial equipment maker Illinois Tool Works Inc. (ITW) Tuesday reported higher third-quarter profit, reflecting increased revenues and margin expansion. The company also lifted its earnings outlook for full year 2014.

For the quarter, net income increased to $531 million or $1.34 per share from $452 million or $1.01 per share in the prior year. Earnings from continuing operations were $1.28 per share, up from $0.90 per share in the year-ago period.

On average, 18 analysts polled by Thomson Reuters expected the company to earn $1.23 per share for the quarter. Analysts' estimates typically exclude special items.

Operating revenues for the quarter grew 3.5 percent to $3.69 billion from $3.57 billion in the preceding year. Sixteen analysts projected quarterly revenues of $3.68 billion.

Organic revenues were up 3.5 percent, with North American and international growth of 4 percent and 3 percent, respectively.

Automotive OEM organic revenue rose 8 percent, Food Equipment's organic revenues increased 5 percent, and Welding's organic revenues grew 5 percent from last year.

Operating margins were 20.9 percent, up 190 basis points from last year.

Scott Santi, president and chief executive officer of the company stated, "These results reflect continued progress in the execution of our enterprise strategy as we position ITW for solid organic growth with best-in-class margins and returns."

Looking ahead to the fourth quarter, the company expects earnings to be in a range of $1.07 to $1.15 per share, on 2 to 3 percent organic revenue growth. Total revenue growth in the quarter is projected to be flat due to currency translation effects.

Analysts currently expect fourth quarter earnings of $1.13 per share, on revenues of $3.64 billion.

For full-year 2014, the firm now expects earnings to be in the range of $4.57 to $4.65 per share, up from its prior range of $4.50 to $4.62 per share. Analysts now expect full-year 2014 earnings of $4.58 per share.

ITW is currently trading at $85.47, up 2.47 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT